CMN are rare brown or black birthmarks which cover up to 80 per cent of the skin surface area. They can vary in size and number, and can occur anywhere on the body. The incidence of larger or multiple lesions is approximately 1 in 20,000 new births per year.
In the study published in the Journal of Investigative Dermatology, 166 people with CMN had their hair and eye colour recorded, and had their blood checked for the MC1R gene. Results were compared to a local control group of 60 unrelated children and with 300 UK children without CMN from the Children of the 90s study (ALSPAC) at the University of Bristol.
The changes in the gene causing red hair (MC1R) were found to be more common in children with CMN and in their families, than those without the condition. In particular, children with CMN were much more likely to carry two copies of those changes, one from each parent. Researchers also identified that certain changes in the gene are associated with children having much more severe skin changes, for example a larger CMN, indicating that MC1R genotype influences the development of these birthmarks when the child is in the womb.
Dr Veronica Kinsler runs the paediatric pigmentary service at GOSH and has a weekly clinic for CMN. She explains: "CMN is a very rare condition, and currently there are no good medical treatments for it. In order to find treatments we need to understand what caused the birthmarks to occur in the first place, and therefore we are investigating the genetics of CMN.
"This study shows an association between the gene that causes red hair and CMN. The gene seems to make CMN more likely to develop, particularly if the child has inherited a copy of the gene from each of their parents. Also some variants of the gene are associated with the CMN being larger.
"If you have red hair in your family, these findings should not worry you, as changes in the red hair gene are common, but large CMN are very rare. So the changes do not cause the CMN to happen, but just increase the risk."
CMN birthmarks can be associated with moles also in the brain, and more rarely with skin cancer (melanoma). Doctors at GOSH regularly check patients for signs of any developments, for example by carrying out MRI scans of the brain. But there is a need for improved treatments for such complications relating to CMN.
Dr Veronica Kinsler explains: "The genetic studies we are doing are also helping to identify which children are at highest risk of these complications. In particular, carrying the changes in MC1R which cause red hair is already known to be associated with melanoma, so this may partly explain why children with CMN have an increased risk of skin cancer. But again, I’d like to stress that families with red hair should not worry as CMN is very rare."
An unexpected finding in the study was that the same changes in the red hair gene that were associated with larger birthmarks also seem to have a more general effect on foetal growth – babies with those particular changes had a significantly higher birth weight than those without. This was confirmed in both the CMN group and in the control group from the Children of the 90s study.
Dr Kinsler says: "The effect on birthweight was a complete surprise. We looked for it when we noticed that certain changes in the gene were associated with the CMN being larger, and wondered if they affected growth more generally. However, it is important to stress that this is a relatively small study for looking at birthweight, and we are now checking this finding in a much larger group of people without CMN."
Doctors at GOSH estimate there are only around 3,000 individuals with severe CMN at the moment in the UK, with lots more who are mildly affected.
The research was funded by the Wellcome Trust and Caring Matters Now charity. Visit www.caringmattersnow.co.uk for more information about CMN.
Real life story: George Robinson
When Karen and Allan Robinson’s first child, George, was born, the whole of his left leg from top to bottom was covered with a birthmark. He also had lots of other smaller birthmarks on other areas of his body. Doctors at the hospital where George was born explained that they thought it was a strawberry haemangioma, the most common type of birthmark, which is a benign tumour of the blood vessels.
Soon afterwards, George was referred to Great Ormond Street Hospital (GOSH), where Dr Kinsler and a colleague recognised that his birthmark was not a haemangioma, but a Congenital Melanocytic Nevus (CMN).
CMN are moles that are present at birth. They can vary in size and number and the incidence of larger or multiple lesions is approximately 1 in 20,000 new births per year.
Doctors at GOSH think there are likely to be around 3,000 severely affected individuals at the moment in the UK, with lots more who are mildly affected.
Since being diagnosed with CMN, George has attended the specialist clinic for children with the condition at GOSH. He has had an MRI scan to check that the CMN was not causing any neurological problems, as sometimes the moles can grow internally. He has also had operations to remove some of the smaller CMN from his wrist and hands.
Karen, Allan and George have been tested to see if they had the melanocortin-1-receptor (MC1R) gene, a gene that is already associated with red hair as part of Dr Veronica Kinsler’s research.
Both Karen, a red head, and her husband were found to have the gene and to have passed it onto George, who despite having the gene has mousey dark blond coloured hair.
For further information, a copy of the journal paper or to arrange interviews, please contact Andrea Ttofa, Great Ormond Street Hospital Press Office, on 0207 239 3039 or email firstname.lastname@example.org
Notes to Editors
Journal reference: Germline melanocortin-1-receptor (MC1R) genotype is associated with severity of cutaneous phenotype in congenital melanocytic naevi – a role for MC1R in human fetal development. Journal of Investigative Dermatology.advance online publication, 10 May 2012; doi:10.1038/jid.2012.95
Great Ormond Street Hospital is one of the world’s leading children’s hospitals with the broadest range of dedicated, children’s healthcare specialists under one roof in the UK. The hospital’s pioneering research and treatment gives hope to children who are suffering from the rarest, most complex and often life-threatening conditions, from across the country and abroad.
Great Ormond Street Hospital Children's Charity needs to raise £50 million a year to help rebuild and refurbish Great Ormond Street Hospital, provide vital up-to-date equipment and fund research into better treatments for the children. You can help us to provide world class care for our patients and families. For more information visit www.gosh.org
Based at the University of Bristol, the Avon Longitudinal Study of Parents and Children (ALSPAC), also known as Children of the 90s, is a world-leading birth cohort study. Between April 1991 and December 1992 it recruited more than 14,000 pregnant women into the study and these women, the children arising from the pregnancy, and their partners have been followed up intensively over two decades. ALSPAC is the most detailed study of its kind and provides a rich resource for the study of the environmental and genetic factors that affect health and development. Through its research it aims to inform policy and practices that will provide a better life for future generations.
About the Wellcome Trust
The Wellcome Trust is a global charitable foundation dedicated to achieving extraordinary improvements in human and animal health. It supports the brightest minds in biomedical research and the medical humanities. The Trust’s breadth of support includes public engagement, education and the application of research to improve health. It is independent of both political and commercial interests. www.wellcome.ac.uk